Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 5, 2007, Pages 925-930

  Pengo, Vittorio ^a   Biasiolo, A ^a   Gresele, P ^b   Marongiu, F ^c   Erba, N ^d   Veschi, F ^d   Ghirarduzzi, A ^e   De Candia, Erica ^f   Montaruli, B ^g   Testa, S ^d   Barcellona, D ^c,i   Tripodi, A ^h   Marongiu, Francesco ⁱ   Veschi, Fabio ⁱ   Ghirarduzzi, Angelo ⁱ   Montaruli, Barbara ⁱ   Marietta, Marco ⁱ   Testa, Sophie ⁱ   Boschi, Letizia ⁱ   Cappelli, Roberto ⁱ   Demicheli, Marta ⁱ   Prisco, Domenico ⁱ   Liotta, A ⁱ   Russo, Umberto ⁱ   Olivieri, Maria Luisa ⁱ   Rizzo, Maria Antonietta ⁱ   Silvestri, Lorena ⁱ   La Rosa, Lucia ⁱ   Micelli, Marina ⁱ   Pergolini, Patrizia ⁱ   Camisasca, Giovanni ⁱ   Muleo, Gaetano ⁱ   Ianacaro, Piergiorgio ⁱ   Ruffatti, Amelia ⁱ   Bizzaro, Nicola ⁱ   Matteucci, Angela ⁱ   Cillari, Enrico ⁱ   Malacrida, Alberto ⁱ   Di Iorio, Giancarlo ⁱ   Frontoni, Rita ⁱ   Poggio, Marina ⁱ   more..

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b University Hospital   (Italy)

^c DEPARTMENT OF RADIOLOGY   (Italy)

^d District Hospital   (Italy)

^e District Hospital   (Italy)

^f FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^g District Hospital   (Italy)

^h FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁱ NONE

Author keywords

Anticoagulants; Diagnosis; Lupus anticoagulant; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 10A; CARBON DIOXIDE; CARDIOLIPIN ANTIBODY; HEPARIN; KAOLIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID DERIVATIVE; SNAKE VENOM;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST; THROMBIN TIME; THROMBOPLASTIN TIME; THROMBOSIS;

EID: 34247894036     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02454.x     Document Type: Article

References (25)

1. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994; 84: 2854-67.
2. Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996; 76: 916.
3. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101: 1827-32.
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
5. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
6. Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Comparison of test methods for lupus anticoagulant: International survey on lupus anticoagulants-I (ISLA-1). Thromb Haemost 1990; 64: 478-84.
7. Roussi J, Roisin JP, Goguel A. Lupus anticoagulants: First French interlaboratory etalanorme survey. Am J Clin Pathol 1996; 105: 788.
8. Jennings I, Kitchen S, Woods TA, Preston FE, Greaves M. Potentially clinically important inaccuracies in testing for lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for blood coagulation. Thromb Haemost 1997; 77: 934-7.
9. Goudemand J, Caron C, De Prost D, Derlon A, Borg JY, Sampol J, Sie P. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The working group on Hemostasis of the Societe' Francaise de Biologie Clinique for the Groupe d'Etudes sur l'Hemostase et la Thrombose. Thromb Haemost 1997; 77: 336-42.
10. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisloff F. The lupus ratio test. An interlaboratory study on the detection of lupus anticoagulants by an aPTT-based, integrated and semi quantitative test. Fifth international survey of lupus anticoagulants-ISLA 5. Thromb Haemost 2000; 83: 704-8.
11. Jennings I, Greaves M, Mackie IJ, Kitchen S, Woods TA, Preston FE. Lupus anticoagulant testing: Improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002; 119: 364-9.
12. Arnout J, Meijer P, Vermylen J. Lupus anticoagulant testing in Europe: an analysis of results from the first European concerted action on thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human β2-glycoprotein I. Thromb Haemost 1999; 81: 929-34.
13. Jennings I, Mackie I, Arnout J, Preston FE, on behalf of the UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2004; 2: 2178-84.
14. Tripodi A, Biasiolo A, Chantarangkul V, Pengo V. Lupus anticoagulant (LA) testing: Performance ofclinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clin Chem 2003; 49: 1608-14.
15. Lensing AWA, Prandoni P, Prins MH, Büller HR. Deep-vein thrombosis. Lancet 1999; 353: 479-85.
16. Thiagarajan P, Pengo V, Shapiro SS. The use of dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-73.
17. Pengo V, Biasiolo A, Rampazzo P, Brocco T. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti β2-glycoprotein I antibodies. Thromb Haemost 1999; 81: 256-8.
18. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the antiphospholipid syndrome. Br J Haematol 1997; 98: 887-92.
19. Tripodi A, Chantarangkul V, Clerici M, Mannucci PM. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Thromb Haemost 2002; 88: 583-6.
20. 2 -glycoprotein-I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
21. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-8.
22. 2-glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.
23. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993; 70: 787-93.
24. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
25. Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile. Thromb Haemost 1999; 81: 695-700.